CD274 and neoplasm: A recent study from a melanoma clinical trial suggested that anti-PD1/PD-L1 based therapy is more effective than traditional chemotherapy, suggesting that the tumor immune microenvironment (TIME) may have a certain regulatory effect on tumor [4].